Emerging Markets Earnings Roundup: Johnson & Johnson, Abbott (Part 1)
This article was originally published in PharmAsia News
Executive Summary
Emerging markets received a lot of attention during the fourth quarter earnings calls of both Abbott Laboratories and J&J. CEOs at both companies proved upbeat on the year ahead and talked about momentum across product lines from medical devices to pharmaceuticals.